Castleman's disease and retroviral therapy

Transfusion and Apheresis Science

Volumn 37, Issue 1, 2007, Pages 81-84

  Kenyon, Chris ^a   Pillay, Komala ^e   Jacobs, Peter ^a,b,c,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d Department of Haematology   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; EFAVIRENZ; LAMIVUDINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; STREPTOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; ASPIRATION BIOPSY; BURKITT LYMPHOMA; CASE REPORT; CD4+ T LYMPHOCYTE; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; KAPOSI SARCOMA; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; RETROVIRUS; TREATMENT OUTCOME; VIROTHERAPY; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AFRICA SOUTH OF THE SAHARA; BURKITT LYMPHOMA; FATAL OUTCOME; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 8, HUMAN; HUMANS; MODELS, BIOLOGICAL; REVERSE TRANSCRIPTASE INHIBITORS; SARCOMA, KAPOSI; TUBERCULOSIS, PULMONARY;

EID: 35348880857     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.04.011     Document Type: Article

References (14)

1. Castleman B., and Towne V.W. Case records of the Massachusetts General Hospital: Case No. 40231. N Engl J Med 250 (1954) 1001-1005
2. Jacobs P., Wood L., and Jogessar V. Refractory Castleman's disease. Hematology 3 (1998) 299-302
3. Waterston A., and Bower M. Fifty years of multicentric Castleman's disease. Acta Oncol 43 (2004) 698-704
4. Aaron L., Lidove O., Yousry C., Roudiere L., Dupont B., and Viard J.P. Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: the impact of highly active antiretroviral therapy. Clin Infect Dis 35 (2002) 880-882
5. Oksenhendler E., Carcelain G., Aoki Y., Boulanger E., Maillard A., Clauvel J.P., et al. High level of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 96 (2000) 2069-2073
6. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 129 (2005) 3-17
7. Collins L.S., Fowler A., Tong C.Y., and de Ruiter A. Multicentric Castleman's disease in HIV infection. Int J Std AIDS 17 (2006) 19-24
8. Goedert J.J. Multicentric Castleman disease: viral and cellular targets for intervention. Blood 102 (2003) 2710-2711
9. DeSimone J.A., Pomerantz R.J., and Babinchak T.J. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 133 (2000) 447-454
10. Zietz C., Bogner J.R., Goebel F.D., and Lohrs U. An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS. N Engl J Med 340 (1999) 1923-1924
11. Herrada J., Cabanillas F., Rice L., Maning J., and Pugh W. The clinical behaviour of localized and multicentric Castleman disease. Ann Intern Med 128 (1998) 657-662
12. Corbellino M., Bestetti G., Scalamogna C., Calattini S., Galazzi M., Meroni L., et al. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 98 (2001) 3473-3475
13. Aoki Y., and Tosato G. Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders. Expert Rev Anti Infect Ther 2 (2004) 213-225
14. Berezne A., Agbalika F., and Oksenhendler E. Failure of cidofovir in HIV-associated multicentric Castleman disease. Blood 103 (2004) 4368-4369